R Martos, J Baugh, M Ledwidge, C O’Loughlin, C Conlon, A Patle, ...
Circulation 115 (7), 888-895, 2007
|Natriuretic peptide–based screening and collaborative care for heart failure: the STOP-HF randomized trial|
M Ledwidge, J Gallagher, C Conlon, E Tallon, E O’Connell, I Dawkins, ...
Jama 310 (1), 66-74, 2013
|Implantation of the Melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit: early results from the US clinical trial|
EM Zahn, WE Hellenbrand, JE Lock, DB McElhinney
Journal of the American College of Cardiology 54 (18), 1722-1729, 2009
|Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial|
P Ponikowski, SD Anker, J Szachniewicz, D Okonko, M Ledwidge, ...
Journal of the American College of Cardiology 49 (7), 753-762, 2007
|Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?|
J Lewin, M Ledwidge, C O'Loughlin, C McNally, K McDonald
European journal of heart failure 7 (6), 953-957, 2005
|Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype|
CJ Watson, P Collier, I Tea, R Neary, JA Watson, C Robinson, D Phelan, ...
Human molecular genetics 23 (8), 2176-2188, 2014
|Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?|
P Collier, CJ Watson, V Voon, D Phelan, A Jan, G Mak, R Martos, ...
European journal of heart failure 13 (10), 1087-1095, 2011
|Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care|
K McDonald, M Ledwidge, J Cahill, P Quigley, B Maurer, B Travers, ...
Journal of cardiac failure 8 (3), 142-148, 2002
|The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients|
R O'Hanlon, P O'Shea, M Ledwidge, C O'Loughlin, S Lange, C Conlon, ...
Journal of cardiac failure 13 (1), 50-55, 2007
|MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure|
CJ Watson, SK Gupta, E O'Connell, S Thum, N Glezeva, J Fendrich, ...
European journal of heart failure 17 (4), 405-415, 2015
|Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover|
R Martos, J Baugh, M Ledwidge, C O'Loughlin, NF Murphy, C Conlon, ...
European journal of heart failure 11 (2), 191-197, 2009
|Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone|
GJ Mak, MT Ledwidge, CJ Watson, DM Phelan, IR Dawkins, NF Murphy, ...
Journal of the American College of Cardiology 54 (18), 1674-1682, 2009
|Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability|
B Travers, C O'Loughlin, NF Murphy, M Ryder, C Conlon, M Ledwidge, ...
Journal of cardiac failure 13 (2), 128-132, 2007
|Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high‐risk, elderly heart failure population: the potential contributions …|
K McDonald, M Ledwidge, J Cahill, J Kelly, P Quigley, B Maurer, F Begley, ...
European journal of heart failure 3 (2), 209-215, 2001
|Is multidisciplinary care of heart failure cost‐beneficial when combined with optimal medical care?|
M Ledwidge, M Barry, J Cahill, E Ryan, B Maurer, M Ryder, B Travers, ...
European journal of heart failure 5 (3), 381-389, 2003
|Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance: NO and MMP-9 interactions|
S O'Sullivan, C Medina, M Ledwidge, MW Radomski, JF Gilmer
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1843 (3), 603-617, 2014
|Effects of surface active characteristics and solid state forms on the pH solubility profiles of drug–salt systems|
MT Ledwidge, OI Corrigan
International journal of pharmaceutics 174 (1-2), 187-200, 1998
|Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease …|
N Glezeva, V Voon, C Watson, S Horgan, K McDonald, M Ledwidge, ...
Journal of cardiac failure 21 (2), 167-177, 2015
|Quality of life predicts outcome in a heart failure disease management program|
C O'Loughlin, NF Murphy, C Conlon, A O'Donovan, M Ledwidge, ...
International Journal of Cardiology 139 (1), 60-67, 2010
|Getting to the heart of cardiac remodeling; how collagen subtypes may contribute to phenotype|
P Collier, CJ Watson, MH Van Es, D Phelan, C McGorrian, M Tolan, ...
Journal of molecular and cellular cardiology 52 (1), 148-153, 2012